Sermorelin Side Effects & Common Treatment
SERMORELIN SIDE EFFECTS
Sermorelin Side effects, Patients have been known to develop anti- GRF antibodies at least once during treatment with Sermorelin. The significance of these antibodies is not clear and often a positive test at one growth assessment will become negative by the next assessment. The presence of antibodies doesn’t seem to affect growth or appear to be related to a specific adverse reaction profile. No generalized allergic reactions to Sermorelin have been reported.
Many patients on sermorelin therapy have developed anti-GHRH antibodies at least once during treatment. However, the significance and long-term effects of these antibodies are unclear, and a positive test is often only temporary. The presence of these antibodies does not appear to lead to specific adverse effects or modulate growth.
No generalized allergic reactions to Side effects of Sermorelin have been reported. The most common treatment-related adverse event (occurring in approximately one in six patients) is a local injection site reaction, which usually presents as redness, pain, or swelling. The injection site reaction can sometimes be serious; for example, of the 350 patients treated with sermorelin in a clinical trial, three discontinued therapies because of these injection site reactions. Other treatment-related adverse events were rare, with an incidence of <1%, and included hives, headache, sleepiness, flushing, dysphagia, dizziness, and hyperactivity.
There is little evidence to suggest that sermorelin is associated with any drug abuse or dependence and there have been no reports of this from clinical trials.
The most common treatment-related adverse event (occurring in about 1 patient in 6) is local injection reaction characterized by pain, swelling or redness. Of 350 patients exposed to Sermorelin in clinical trials, three discontinued therapy due to injection reactions. Other treatment-related adverse events had individual occurrence rates of less than 1% and include a headache, flushing, dysphagia, dizziness, hyperactivity, somnolence, and urticaria.
When administered intravenously for diagnostic use, the following adverse reactions have been noted: flushing of the face, injection site pain, redness and/or swelling, nausea, headache, vomiting, dysgeusia, pallor and tightness in the chest.
WHAT IS SERMORELIN?
Drug Abuse and Dependence
The clinical pharmacology suggests that Sermorelin is very unlikely to be associated with drug abuse or dependence and there have been no reports of this from clinical trials.
*information available through RxList (drug index)